Opening session
Welcome and Introduction
Silvia C. Formenti, MD Weill Cornell Medical College New York, NY, USA
Jedd Wolchok, MD, PhD Weill Cornell Medical College New York, NY, USA
Three days of scientific discussions, keynote lectures and expert sessions dedicated to radiation therapy, nuclear medicine and anti-tumor immunity.
Download the program September 23–25, 2026 Three-day scientific program
New York, USA Medical scientific meeting
Day 1
2:00 pm – 6:30 pmWednesday, September 23, 2026
Keynote Lecture
Sponsored by TBDTheranostics and Nuclear Medicine
Evolving role of theranostics for imaging and treatment of prostate cancer.
Robert Flavell University of California, San Francisco San Francisco, CA, USA
Main Program
Session I
Supported by TBDRadionuclide Therapy and Anti-Tumor Immunity
Chair: Vikram Bhadrasain, NIH
Panelist
John Babich Ratio Therapeutics Boston, MA, USA
Adapting radiopharmaceutical therapy dosing to maximize response in combination with immunotherapies
Zachary Morris University of Wisconsin Madison, WI, USA
PARP-targeted theranostic approach to image and treat ovarian cancer.
Sarah Gitto University of Pennsylvania Philadelphia, PA, USA
Selected abstract
Short presentation selected from abstracts
Coffee Break 4:30 pm – 5:00 pm
Session II
Supported by TBDImaging Radiation-Induced Immune Response
Chair: TBD
Radiomics-based imaging of radiation-induced immune modulation
Eric Deutsch Gustave Roussy Paris, France
CD8 immunoPET for imaging immune responses to radiation
Anna Wu City of Hope Los Angeles, CA, USA
Imaging-guided radioligand therapy in glioblastoma: from precision targeting to treatment response.
Gabriela Kramer-Marek Institute for Cancer Research London, UK
Selected abstract
Short presentation selected from abstracts
6:30 pm End of Day 1
Day 2
8:30 am – 8:30 pmThursday, September 24, 2026
Keynote Lecture
Sponsored by TBDMechanisms of Immune Tolerance
Mechanisms of Immune Tolerance: Balancing Immunity and Homeostasis
Julie Magarian Blander Weill Cornell Medicine New York, NY, USA
Session III
Supported by TBDImmune Tolerance Mechanisms: Implications for Radiation Therapy
Chair: TBD
Interception, REstitution, and Prevention - IREP for Immunity'
Michael Lotze University of Pittsburgh
Title TBD
Presentation title to be announced
Pier Giuseppe Pelicci Istituto Europeo di Oncologia
Thymus Health and Immune Tolerance
Silvia Formenti Weill Cornell Medicine New York, NY, USA
Radiotherapy-induced remodeling of the glioblastoma microenvironment as a therapeutic vulnerability
Alexander Pietras Lund University Lund, Sweden
Coffee Break 10:55 am – 11:25 am
Session IV
Supported by TBDImmune Effects of Radiation in the Clinic: Contributions from the ROBIN Centers
Chair: TBD
ImmunoRad ROBIN
Encouse Golden Weill Cornell Medicine New York, NY, USA
Chemoradiation reprograms myeloid cells in the tumor microenvironment
Julie Schwarz Washington University in St. Louis St. Louis, MO, USA
Optimizing Radiation in the Context of Preoperative Immune Therapy in Head and Neck Cancer
Jonathan Schoenfeld Harvard Medical School Boston, MA, USA
GenRad ROBIN
Timothy Chan Cleveland Clinic Cleveland, OH, USA
Oligometastasis (OligoMET) Center: Using Biomarker Correlates from Prostate Cancer Clinical Trials to Improve Future Outcomes
Chad Tang MD Anderson Houston, TX, USA
Discussion
Questions & Answers
Lunch Break 1:15 pm – 2:15 pm
Session V
Supported by TBDHow to Harness RT to Potentiate an Immune Response
Chair: TBD
Navigating the Benefits and Challenges
Sana Karam Washington University in St. Louis St. Louis, MO, USA
Radiation and Metabolism – Lung
Arta Monjazeb University of California, Davis Davis, CA, USA
Modulators of Radiation-Immunotherapy Synergy in Breast Cancer
Gaorav Gupta University of North Carolina at Chapel Hill Chapel Hill, NC, USA
Coffee Break 3:30 pm – 4:00 pm
Session VI
Supported by TBDNormal Tissue vs. Tumor Response to Radiation
Chair: TBD
The Impact of FLASH Radiotherapy on the Immune Environment of Normal and Tumor Tissues: A Window for Therapeutic Exploitation
Constantino Koumenis University of Pennsylvania Philadelphia, PA, USA
Smart Synergy: Combing Radiation and Artificial Intelligence to Unlock Immunotherapy Response
James Welsh MD Anderson Houston, TX, USA
FLASH-based radioimmunotherapy in brain tumor
Yi Fan University of Pennsylvania Philadelphia, PA, USA
Selected abstract
Short presentation selected from abstracts
Panel Discussion
Supported by TBDIntratumoral Immunotherapy with Radiation Therapy to Enhance Anti-Tumor Immunity
5:30 pm – 6:30 pm
Sana Karam Washington University in St. Louis St. Louis, MO, USA
Howard Kaufman Ankyra Therapeutics Cambridge, MA, USA
Aisha Hasan Johnson & Johnson
6:30 pm to 8:30 pm
Networking Poster Session
Scientific posters, discussions and networking.
Day 3
8:30 am – 9:00 pmFriday, September 25, 2026
Keynote Lecture
Sponsored by TBDAdaptive Tumor Response to Radiation
Spooky action at a distance
Ralph Weichselbaum University of Chicago Chicago, IL, USA
Session VII
Supported by TBDInnate Immunity and Radiation Therapy
Chair: TBD
Macrophages and Radiation
Nir Ben Chetrit Weill Cornell Medicine New York, NY, USA
Apoptotic competence regulates innate immune signaling in irradiated cancer cells
Lorenzo Galluzzi Fox Chase Cancer Center Philadelphia, PA, USA
Type I interferon in Radiation Therapy: Friend or Foe?
Andy Minn Memorial Sloan Kettering New York, NY, USA
Selected abstract
Short presentation selected from abstracts
Selected abstract
Short presentation selected from abstracts
Coffee Break 11:10 am – 11:40 am
Session VIII
Supported by TBDThe Microbiome in the Context of Radiation
Chair: TBD
Interplay between the microbiota, metabolites, and cancer immunosurveillance
Marine Fidelle Gustave Roussy Paris, France
Microbiome regulation of anti-tumor immunity elicited by radiation
Stephen Shiao Cedars-Sinai Los Angeles, CA, USA
Microbiome-Driven Immune Programming of Radiotherapy Responses
Andrea Facciabene University of Pennsylvania Philadelphia, PA, USA
Lunch Break 12:55 pm – 2:30 pm
Session IX
Supported by TBDRole of Radiation in Cell Therapy
Chair: TBD
Radiation induced immune dysfunction
Chandan Guha Albert Einstein College of Medicine New York, NY, USA
Enhancing CAR T-Cell Efficacy in Lymphoma with Low-Dose Irradiation
Monica Guzman Weill Cornell Medicine New York, NY, USA
Targeting Immune Modulators with CAR-T/CAAR-T to Reduce Autoimmune Toxicities
Bo Lu University of Missouri Columbia, MO, USA
Selected abstract
Short presentation selected from abstracts
Panel Discussion
Supported by TBDArtificial Intelligence in Radiation and Immunotherapy
3:55 pm – 5:00 pm
James Welsh MD Anderson Houston, TX, USA
Akshay Nanduri Onc AI Waterloo, ON, Canada
Joe Deasy Memorial Sloan Kettering New York, NY, USA
Aaron Berliner Weill Cornell Medicine New York, NY, USA
5:00 pm End of Scientific Program
© IMMUNORAD 2026®, Créé par CED-WEB
